Who we are
ADIPSO was founded in November, 1989, with the aim of providing positive assistance to people affected by psoriasis and psoriatic arthritis. The objective of the Association is to inform patients on the latest treatments available, increase public awareness on the specific problems regarding psoriasis, defend the right of psoriatic patients and promote Genetic Research on psoriasis and psoriatic arthritis. ADIPSO has worked hard to have psoriasis and psoriatic arthritis officially recognized as social and disabling diseases. This objective was finally achieved, thanks our continuous “presence” in the Italian Ministry of Health, with Law Decree 226. Thanks to this law, drugs used for the treatment of psoriasis are now in Class A (i.e. covered by the Italian NHS).
The Association also represents patients in the GRAPPA (Group Research Assessment Psoriasis and Psoriatic Arthritis) workgroup for research and assessment of psoriasis and psoriatic arthritis, formed by a group of Rheumatologists, Dermatologists, Geneticists, Epidemiologists and Patients Associations. We are also members of EULAR (European League Against Rheumatism).
ADIPSO has also been a member of EPF (European Patients’ Forum) and has created a “Pan European Psoriasis Patient Organizations Forum”
